comscoreFebruary 2015 Research Highlights

February 2015 Research Highlights

Brian Wojciechowski, MD, discusses Ibrance, newly approved to treat some metastatic breast cancers.
Oct 19, 2016
00:00
Download
00:00

In this Breastcancer.org podcast, Dr. Brian Wojciechowski discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015.

Listen to the podcast to hear Dr. Wojciechowski explain:

  • how Ibrance works

  • who is eligible to take Ibrance

  • how Ibrance is taken and whether any other medicines are taken with it

  • the side effects that Ibrance can cause

About the guest
 
Brian Wojciechowski headshot
Brian Wojciechowski, MD

Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.

— Last updated on May 2, 2022, 2:44 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate